NCT06943521 2025-12-11A Study of MT-4561 in Patients With Various Advanced Solid TumorsTanabe Pharma America, Inc.Phase 1/2 Recruiting27 enrolled
NCT04278144 2025-09-15A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid TumorsBolt Biotherapeutics, Inc.Phase 1/2 Terminated175 enrolled
NCT06975410 2025-08-01Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid TumorsYuhan CorporationPhase 1/2 Recruiting80 enrolled
NCT06239194 2025-06-22Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsModeX Therapeutics, An OPKO Health CompanyPhase 1/2 Recruiting115 enrolled
NCT05253053 2025-06-12To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid TumorsTransThera Sciences (Nanjing), Inc.Phase 1/2 Completed84 enrolled
NCT05784688 2025-03-30Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid TumorsTiumBio Co., Ltd.Phase 1/2 Recruiting140 enrolled